2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride,
SB-505124,
SB505124,
SB-505124,
694433-59-5,
SB505124,
SB 505124,
2-(4-(benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl)-6-methylpyridine,
CHEMBL226838,
2-(5-benzo[1,3]dioxol-5-yl-2-tert-butyl-3h-imidazol-4-yl)-6-methylpyridine,
2-(5-(benzo[d][1,3]dioxol-5-yl)-2-tert-butyl-1H-imidazol-4-yl)-6-methylpyridine,
2-[4-(1,3-Benzodioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl]-6-methylpyridine,
2-[4-(2H-1,3-benzodioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl]-6-methylpyridine,
2-[5-(1,3-Benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-4-yl]-6-methylpyridine,
MLS006010969,
SCHEMBL373422,
GTPL6049,
CTK8E3615,
KS-00000XPS,
AOB1766,
AOB5688,
DTXSID50431926,
EX-A217,
CHEBI:100922,
BCPP000071,
HMS3655F08,
BCP22718,
2707AH,
BDBM50298220,
MFCD20926329,
s2186,
ZINC16052825,
AKOS024457513,
API0010255,
CS-1582,
RTX-012858,
SB19487,
2-[4-(1,3-benzodioxol-5-yl)-2-tert-butyl-1H-imidazol-5-yl]-6-methylpyridine,
NCGC00165889-01,
NCGC00165889-02,
AC-27412,
AK286365,
BC600335,
HY-13521,
SC-96721,
SMR004702773,
BCP0726000127,
SW219461-1,
2-(4-(benzo[d][1,3]dioxol-5-yl)-2-(tert-butyl)-1H-imidazol-5-yl)-6-methylpyridine,
2-[4-(1,3-benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-5-yl]-6-methyl-pyridin,
2-[4-(1,3-Benzodioxol-5-yl)-2-(1,1-dimethylethyl)-1H-imidazol-5-yl]-6-methyl-pyridine,
2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride,
D0Q5UH,
SB-505124 hydrochloride,
TGF-beta RI Inhibitor III,
CHEMBL1824446,
C20H21N3O2,
CID9858940,
B2289,
A11157,
C519132,
356559-13-2,
2-(5-benzo(1,3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride,
2-(5-benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methyl-pyridine,
2-(5-benzo[1,3]dioxol-5-yl-2-tert-butyl-3h-imidazol-4-yl)-6-methylpyridine hydrochloride,
SB-505124, 98%, a selective inhibitor of TGFbetaR for ALK4, ALK5 - 10MG 10mg,